This inventor holds 3 USPTO granted patents and 4 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignees: Askbio Inc., Asklepios Biopharmaceutical, Inc.. Active years: 2022-2026.
Company Filing History:
Years Active: 2022-2026
Title: Graham Whyteside: Innovator in Gene Expression Regulation
Introduction
Graham Whyteside is a notable inventor based in Falkirk, GB. He has made significant contributions to the field of gene expression regulation, holding a total of 3 patents. His work focuses on innovative methods that enhance the understanding and application of gene expression in eukaryotic cells.
Latest Patents
Among his latest patents is the invention titled "LIVER-SPECIFIC INDUCIBLE PROMOTERS AND METHODS OF USE THEREOF." This invention relates to the use of regulatory nucleic acid sequences that can regulate gene expression in eukaryotic cells and are responsive to the unfolded protein response (UPR). The patent discloses regulatable introns and UPR-inducible promoters that effectively regulate gene expression. Additionally, it includes recombinant expression constructs that comprise such regulatory nucleic acid sequences, allowing for the induction of expression of the encoded product by invoking the UPR in a eukaryotic cell containing the construct. The methods of using these constructs, along with associated vectors and cells, are also detailed in the patent.
Career Highlights
Graham has worked with prominent companies in the biopharmaceutical sector, including Asklepios Biopharmaceutical, Inc. and Askbio Inc. His experience in these organizations has contributed to his expertise in the field of gene therapy and expression regulation.
Collaborations
Throughout his career, Graham has collaborated with notable professionals such as Anne Braae and Michael Roberts. These collaborations have further enriched his research and development efforts in gene expression technologies.
Conclusion
Graham Whyteside's innovative work in gene expression regulation has led to valuable patents that advance the field of biotechnology. His contributions continue to influence research and applications in gene therapy and related areas.